Table 1

Clinical characteristics of participants at baseline evaluation and description of observations.

CLINICAL


S1
S2
S3
S4
S5
All

Age
72
73
78
79
85
77.4 ± 5.2
Diagnostic
Immob. Syndrome
Fractured femur
Fractured hip
Femoral amput.
Fractured hip Stroke
NA
SMAF (0 to -87)
-35
-30
-38
-19
-40
-32.4 ± 8.4
Berg (0–56)
5
10
29
37
16
19.4 ± 13.3
TUG (sec)
*
56.7
34.6
61.0
82.0
58.6 ± 19.4
5 m walk (sec)
*
22.1
12.5
*
18.3
17.6 ± 4.8

OBSERVATIONS

N of Sessions
8
12
10
12
20
62
Total time (min)
58.4 ± 9.1
52.0 ± 3.8
57.2 ± 12.1
43.5 ± 6.2
59.5 ± 8.7
47.8 ± 12.2
Active time (min)
39.8 ± 11.3
33.2 ± 6.5
19.3 ± 9.3
33.0 ± 7.6
33.6 ± 9.9
27.0 ± 11.1
Density (%)
67.8 ± 13.3
63.9 ± 12.0
34.1 ± 14.4
75.5 ± 11.5
48.2 ± 8.7
56.8 ± 18.1

Values are presented as mean ± SD. All patients needed to use a walker in order to perform mobility tests, like TUG and the 5-m walk. An asterisk (*) indicates that the patient was unable to accomplish a given test at baseline evaluation. Mean values for performance tests were calculated only on available data. Density represents the proportion of total active time on total time of therapy for all sessions. Immob. Syndrome is for Immobilization Syndrome. Femoral amput. is for Femoral Amputation.

Choquette et al. Journal of NeuroEngineering and Rehabilitation 2008 5:20   doi:10.1186/1743-0003-5-20